Progress in Molecular Biology and Translational Science
136,00 €*
Sofort verfügbar, Lieferzeit: 1-3 Tage
Produktnummer:
9780128177402
Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications, The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharid, Heparinoids as Clinically Used Drugs, Marine Glycan-Derived Therapeutics in China, Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases-30 Years Clinical Applications in China, and more.
| EAN: | 9780128177402 |
|---|---|
| Sprache: | Englisch |
| Produktart: | Gebunden |
| Herausgeber: | Zhang, Lijuan |
| Verlag: | Academic Press Elsevier Science & Technology |
| Untertitel: | Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B |
| Schlagworte: | Heparin Polysaccharide |
| Größe: | 229 × 152 × 29 |
| Gewicht: | 970 g |
